Blog

Roadmaps to the Intertwined IP and Regulatory Regimes in China
Moderator: Jeremy K. McKown, Johnson & Johnson, New Brunswick, NJ

Developments in Pharmaceutical IP and Regulatory Coordination Efforts to
Stimulate Faster and Better Pharmaceutical Development in China Using Patent Law and Policy for Incentivizing Green Technology Innovation in China
Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China

Presented by: AIPPI-US/IP in China Committees

Speakers

• Cao, Wen

  Shanghai Office of NTD | Senior Partner

  Ms. Cao serves as the principal of NTD Shanghai Office.
• Luo, Juhua

  CCPIT Patent and Trademark Law Office

  Mr. Luo's practice focuses mainly on prosecution of patent.
• McKown, Jeremy K.

  Johnson & Johnson | Global Patent Head

  Jeremy is the Global Patent Head of Johnson & Johnson’s pharmaceutical business, where he manages a global team of attorneys and professionals focused on creating robust patent portfolios and providing strategic counsel to its’ Innovative Medicine companies. In addition, he advises on material R&D transactions and IP litigations, and actively works with external trade associations to ensure we have meaningful IP policies. Previously, he led the R&D Legal team responsible for drafting and negotiating complex agreements for J&J’s Innovative Medicine companies.